Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Current and future therapies for primary Sjögren syndrome

(2021) Raphaèle Seror et al.   Nature Reviews Rheumatology

Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure

(2021) Suzanne Arends et al.   Lancet Rheumatology

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial

(2021) Simon J Bowman et al.   LANCET

A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome

(2020) Maria Juarez et al.   RHEUMATOLOGY

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study

(2019) Jacques-Eric Gottenberg et al.   BMJ-British Medical Journal

Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

(2019) Thomas Dörner et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome

(2018) E. William St.Clair et al.   Arthritis & Rheumatology

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

(2017) Simon J. Bowman et al.   Arthritis & Rheumatology

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies

(2016) Raphaèle Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

(2016) G. Nocturne et al.   Arthritis & Rheumatology

Comparative performance of heterogeneity variance estimators in meta-analysis: a review of simulation studies

(2016) Dean Langan et al.   Research Synthesis Methods

Development of the Sjögren’s Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy

(2015) Divi Cornec et al.   RHEUMATOLOGY

Treatment of Primary Sjögren Syndrome With Rituximab

(2014) Valérie Devauchelle-Pensec et al.   ANNALS OF INTERNAL MEDICINE

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

(2014) Raphaèle Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management

(2014) Gaetane Nocturne et al.   BRITISH JOURNAL OF HAEMATOLOGY

Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome

(2014) Jacques-Eric Gottenberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Health-related utility values of patients with primary Sjögren's syndrome and its predictors

(2013) Dennis Lendrem et al.   ANNALS OF THE RHEUMATIC DISEASES

Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort

(2013) Jacques-Eric Gottenberg et al.   PLoS One

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients

(2013) R. Seror et al.   ARTHRITIS CARE & RESEARCH

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

(2011) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Subgroup identification from randomized clinical trial data

(2011) Jared C. Foster et al.   STATISTICS IN MEDICINE

A Simplified Quantitative Method for Assessing Keratoconjunctivitis Sicca From the Sjögren's Syndrome International Registry

(2009) John P. Whitcher et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

(2009) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Novel evidence-based systemic lupus erythematosus responder index

(2009) Richard A. Furie et al.   ARTHRITIS AND RHEUMATISM